推荐产品
一般描述
应用
特点和优势
- Amplifies fragmented/extremely small quantities of DNA: Yields from ChIP or FFPE, which are 200-500 bp are easily amplified by Random priming technology.
- Facilitates sequencing from as little as 100 pg of DNA
- Enhanced primers for complete genome coverage, minimal sequence bias, and amplicon size ideal for next generation sequencing (NGS)
- Cost-effective: No longer requires an additional NGS library prep step
- Compatible with Illumina® next-generation sequencing
组分
其他说明
- A 20 μL Amplification 2 reaction will produce >100 ng of amplified double-stranded cDNA when starting with 100 pg to 5 ng of high-quality DNA. Higher input quantities and higher quality DNA template generally result in increased yields. For damaged DNA, such as from FFPE, 1–50 ng input DNA is recommended.
- The dual index adapter primers (AP100) provided in this kit will only work for one sample. If pooling of samples for sequencing is required, the user must provide additional index primer sets. See example index primer sequences on page 2 of the technical bulletin.
法律信息
免责声明
商品
SeqPlex™-I WTA kit amplifies RNA for NGS, enabling genomic studies from limited samples.
SeqPlex™-I WTA kit amplifies RNA for NGS, enabling genomic studies from limited samples.
SeqPlex™-I WTA kit amplifies RNA for NGS, enabling genomic studies from limited samples.
SeqPlex™-I WTA kit amplifies RNA for NGS, enabling genomic studies from limited samples.
相关内容
Major technological advances have made the production of monoclonal antibodies quicker and more efficient. There are three established platforms for antibody discovery. We offer reagents for production of monoclonal antibody libraries using each of these techniques.
技术方面的重大进展让单克隆抗体生产更快速高效。现有三个成熟的抗体发现平台。我们提供基于不同技术生产单克隆抗体所需的试剂。
Major technological advances have made the production of monoclonal antibodies quicker and more efficient. There are three established platforms for antibody discovery. We offer reagents for production of monoclonal antibody libraries using each of these techniques.
Major technological advances have made the production of monoclonal antibodies quicker and more efficient. There are three established platforms for antibody discovery. We offer reagents for production of monoclonal antibody libraries using each of these techniques.
我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系技术服务部门